Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search
 

Purveyor

(29,876 posts)
Wed Jun 22, 2016, 07:39 PM Jun 2016

Drug Stocks Surge After U.S. Says Cost Panel Will Wait Until 2017

Source: Bloomberg

Drug and biotechnology stocks surged Wednesday after the U.S. government said a cost-cutting mechanism created under Obamacare, known as the Independent Payment Advisory Board, or IPAB, will likely be triggered in 2017, not this year as some investors had feared.

The 2017 projection is in line with estimates from last year by Medicare’s Board of Trustees, which on Wednesday released its annual report on the U.S. health-care program’s long-term finances. The trustees also said that Medicare’s hospital insurance trust fund, which finances some care under the program, will be unable to meet all of its obligations in 2028,
two years earlier than projected.

Investors had been watching nervously for news of the determination, concerned that it could trigger this year and set in motion reductions in Medicare payments to biotech and pharmaceutical companies, as well as other health-care firms. The Nasdaq Biotechnology Index of 189 stocks had fallen for 11 of the past 12 trading days as of Tuesday’s close.

The biotech index rose as much as 2.7 percent for the biggest intraday gain in more than a month, and the broader Standard & Poor’s 500 Health Care Index of 56 stocks was up 1.4 percent.



Read more: http://www.bloomberg.com/news/articles/2016-06-22/medicare-fund-to-run-short-in-2028-ipab-still-projected-in-2017

Latest Discussions»Latest Breaking News»Drug Stocks Surge After U...